Hutch News
Results per Page:
On World AIDS Day, a broad view of continuing work
Teams of Fred Hutch scientists test vaccines, treatments, new strategies
Biostatistician Dr. Deborah Donnell named AAAS Fellow
Honor recognizes her key role in HIV prevention studies
Injectable HIV drug prevents infections
Early data shows fewer infections than with daily pill; trial halted
HIV prevention gains bring hope — and challenges
Injectable PrEP and other options are in the pipeline, and that makes clinical trials more complicated
CDC recommends daily pill for those at high risk for HIV
Researchers work on long-lasting injectable drug; vaccine still ‘the holy grail’
Six-month drug regimen cuts HIV risk for breastfeeding infants
SCHARP data shows longer nevirapine treatment reduces infection by half for babies with HIV-infected mothers, 75 percent for infants of untreated moms
Study shows ART lowers HIV transmission
Antiretroviral therapy associated with 92 percent decreased risk of HIV transmission among HIV-1 discordant couples in large, multinational study
The challenge of nevirapine resistance
Anthony Mwatha finds mothers and infants with some HIV subtypes show increased resistance to drug used to prevent perinatal transmission of HIV in developing countries